Plasma Calmodulin as a Biomarker of Subclinical Cardiovas-cular Disease in Pediatric Chronic Kidney Disease_Supplementary data

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-26
DOI
https://doi.org/10.5281/zenodo.15287668
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma Calmodulin as a Biomarker of Subclinical Cardiovas-cular Disease in Pediatric Chronic Kidney Disease_Supplementary data

Zenodo (CERN European Organization for Nuclear Research)
Heart Failure Treatment and Management
article

Plasma Calmodulin as a Biomarker of Subclinical Cardiovas-cular Disease in Pediatric Chronic Kidney Disease_Supplementary data

article en

Abstract

No abstract available for this paper.
Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Heart Failure Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Plasma Calmodulin as a Biomarker of Subclinical Cardiovas-cular Disease in Pediatric Chronic Kidney Disease_Supplementary data · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS